Skip to content
Company Terminals Nifty 50 Company TerminalsNifty 500 Index TerminalRecently Listed IPOs Markets Bhav Dhan Index: fear and greed, decodedFII DII data today, decodedNifty P/E, measured five waysMorning Open: before the bellEvening Close: the day, readThis season's results, read forensicallyAlerts by email and TelegramMarket Movers: why stocks moved IPO Intel Live and upcoming IPOsRecently listed: score vs outcomeSME IPO forensics Research Research and analysisIndustry research Calculators All calculatorsGold desk Services Roadmap Pricing Get started →
The $13 Billion Machine: Inside the Macro-Economics of the 2026 FIFA World CupAlibaba share price is up 16% today. what next for Baba stock?IPO Allotment status check online by PAN number 2025UnitedHealth (UNH Stock): You should stay away from itQ4 results live updates: Adani Group companies in focusThe $13 Billion Machine: Inside the Macro-Economics of the 2026 FIFA World CupAlibaba share price is up 16% today. what next for Baba stock?IPO Allotment status check online by PAN number 2025UnitedHealth (UNH Stock): You should stay away from itQ4 results live updates: Adani Group companies in focus
NSE: CAPLIPOINTISIN INE475E01026

Caplin Point Laboratories Ltd.

HealthcareNifty 500Statement-builtBalanced risk
₹2,298.40
−162.40 (−6.60%)
Close 2026-10-16
52-week range
₹1,558−18.9% from high₹2,835
Last 6 months +76.9%
Trend
vs 50-DMA −10.4%vs 200-DMA +0.4%Volatility 72%
Analyst view from the market data feed
63% bullish
2 analystsmean rating 1.50
Price
₹2,298.40
Mkt cap
₹17,619 cr
P/E (TTM)
30.0xexcl. exceptional items
P/B
4.88x
Book value
₹439.6
ROE
21.2%
Op margin
31.4%
Net margin
29.6%
D/E
0.00
Div yield
0.35%
Market today: Funded rallyBhav 58 · Dhan 70 · 6 NovBhav Dhan Index →
Consolidatedstandalone figures are read separately and never mixed into these tables
What this company actually does

A plain-language read of the business, how it actually earns, where the edge is, and the economics of every reported segment — taken from the annual report and investor presentation, not a one-line industry label.

  • Business model in plain language
  • The revenue engine — what actually generates cash
  • Segment revenue, PBIT, margin and capital employed
  • Operating KPIs — volumes, capacity, utilisation
Live once this company's filings, calls and disclosures have been read.

What's newsince the last filing we processed

Annual report Annual Report 2017 Open
Earnings call Oct 2019 Open
Announcement 7 Oct - Regulation 74(5) compliance certificate for quarter and half year ended September 30, 2026. Open

Price in context split-adjusted

1M−16.1%
6M+30.2%
1Y+16.0%16.0% a year
3Y+116.4%29.3% a year
5Y+154.0%20.5% a year
From high−18.7%worst -68%
vs Nifty, 1Y+18.2 ptsNifty −2.2%
Volatility72%a year

Trading at 21.4x earnings against its own median of 26.6x: 0.3 standard deviations below its usual range. This compares the company with its own history, not with other companies.

How to read this: Price shows the closing price with its 50-day (amber) and 200-day (grey) averages; bars at the bottom are daily volume, green on up days and red on down days; dashed lines mark the 52-week high and low. vs Nifty 50 starts both at 100 so you can see which did better over the period. P/E shows what the market paid for each rupee of profit, inside the band it usually trades in. Drawdown shows how far below its best price the share has been. Hover anywhere for the numbers on that day.

What you must understand

The three to six things that actually matter about this company, each with the exact filing and note it came from — never a fact without the context that makes it meaningful.

  • Reported profit vs operating profit
  • Management narrative vs the numbers
  • Standalone vs consolidated divergence
  • Audit opinion vs headline optimism
Live once this company's filings, calls and disclosures have been read.

Reading the Statements forensic interpretation

What the numbers mean when read together — computed from the filings, not a score.

Cash lags profit somewhat

Operating cash is 80% of trailing profit — a modest gap worth keeping an eye on.

Why this reading: Noted with caution: a mild gap that is commonly benign (working-capital timing) but worth tracking across years.

Full read

Operating cash ₹523 cr vs trailing profit ₹650 cr. Gaps in the 0.5–0.9 range are usually timing, occasionally a early tell.

Capital work-in-progress is sticky

Capital work-in-progress has stayed high (40% of fixed assets) without converting to productive assets — worth checking whether projects are genuinely progressing.

Why this reading: Noted with caution — worth watching, but not yet conclusive on its own. Business has ups and downs; one soft reading is not a verdict.

Full read

CWIP ₹234 cr vs ₹117 cr two years earlier, against fixed assets ₹580 cr. Perennial CWIP that never becomes a fixed asset can hide stalled projects or capitalised costs that should have been expensed.

Profit growing with revenue

Both revenue and profit grew over the last year (15% and 19.6%) — growth is translating to the bottom line.

Why this reading: A positive signal in the numbers, shown for balance alongside the concerns.

Full read

Trailing revenue ₹2,287 cr, trailing profit ₹678 cr. Profit growing at least as fast as revenue indicates operating leverage or pricing power.

Generates free cash

Free cash flow is positive and consistent — the business funds itself after capex.

Why this reading: A positive signal in the numbers, shown for balance alongside the concerns.

Full read

Latest free cash flow ₹275 cr. Negative in only 1 of 12 years. A self-funding business needs less external capital and dilutes less.

Forensic modelscomputed from the filed statements

Every score below is calculated here from the reported numbers — none of it is asserted. Open the notebook at the foot of the section to see each formula with this company's figures in it.

Altman Z″

Needs current assets and current liabilities.

Piotroski F

5 / 8 1 not testable
  • Profitable this year
  • Operating cash positive
  • Return on assets improved
  • Cash exceeds profit
  • Leverage reduced
  • Liquidity improved
  • No share dilution
  • Margin improved
  • Assets working harder
What is this, and how do I read it?

Piotroski F-Score — fundamental momentum — Joseph Piotroski, University of Chicago, 2000, in a study of whether accounting signals could improve returns among cheap stocks.

Nine yes-or-no tests across profitability, leverage and operating efficiency. Each pass scores one. It asks a narrow question: is this business getting better or worse on its own terms, year over year?

Profitability (4 tests)
Positive profit, positive operating cash, improving return on assets, and cash exceeding profit. The last is the quality test — profit that outruns cash is the one to question.
Leverage and liquidity (3 tests)
Falling debt, improving current ratio, no new shares issued. Growth funded by dilution scores zero here.
Operating efficiency (2 tests)
Improving margin and improving asset turnover.

How to read it7 or more suggests improving fundamentals; 3 or fewer suggests deterioration. It measures direction, not quality — a weak company improving can score higher than a strong one holding steady.

Where it failsA single year of comparison, so one unusual year distorts it. Says nothing about valuation, competitive position or management. Piotroski designed it to rank already-cheap stocks, not to judge a company in isolation.

Beneish M

Needs trade receivables, current assets, other expenses.

Cash vs profit

0.75× 11-year cumulative

Accruals are 3.5% of assets. Free cash flow negative in 1 of 12 years.

DuPont — return on equity FY2026

Net margin29.7%× Asset turnover0.54×× Leverage1.20×= ROE19.3%
What is this, and how do I read it?

DuPont decomposition — Devised inside the DuPont Corporation in the 1920s and still the standard way to read a return on equity.

Splits return on equity into its three sources, so the same headline number can be traced to very different businesses.

Net margin
What the company keeps from each rupee of sales. High margin points to pricing power or a genuine cost advantage.
Asset turnover
Sales generated per rupee of assets. High turnover points to efficiency — a retailer earns this way, a utility never will.
Leverage (equity multiplier)
Assets divided by equity. This multiplies whatever the first two produce, in both directions.

How to read itA 20% ROE built on margin and turnover is a different proposition from a 20% ROE built on 3× leverage. The first survives a downturn; the second amplifies it.

Where it failsA single year. Negative equity makes it meaningless. Leverage is structural for lenders, so the third term carries no signal there.

Leverage & coverage FY2026

Debt / equity0.07×
Interest coverage804.00×
ROCE24.0%

Capital that builds FY2023 → FY2026

Capital deployed+62%
Revenue produced+49%
Still in CWIP₹234 cr

Capital and revenue are growing at broadly similar rates — the asset base is being used, not just added to.

The formula notebook — every number above, worked out
Cash vs profit cumulative operating cash flow ÷ cumulative net profit ₹2,462 cr ÷ ₹3,262 cr, over 11 years 0.75× Below 1.0 and persistent means profit is being recognised before the cash arrives.
Accruals (Sloan) (net profit − operating cash flow) ÷ average total assets (₹650 − ₹523) cr ÷ average assets 3.5% The share of profit that is accounting entries rather than cash. Above ~10% is where accruals start to dominate.
DuPont — return on equity net margin × asset turnover × leverage 29.7% × 0.54 × 1.20 19.3% Splits ROE into whether returns come from operations or from borrowing.
Interest coverage EBIT ÷ finance cost ₹804 cr ÷ ₹1 cr 804.00× How many times operating profit covers the interest bill.
Debt to equity borrowings ÷ net worth ₹221 cr ÷ ₹3,370 cr 0.07× Read against the sector — infrastructure carries more than software.
Capital that builds growth in fixed assets + CWIP, against growth in revenue capital +62% vs revenue +49%, FY2023 to FY2026 13pp gap Money going in far faster than revenue coming out. For an incubator this is expected — the test is whether it eventually converts.

Going deepersame statements, harder questions

Montier C-Score

Needs more balance-sheet detail (only 3 of 6 flags testable).

Return on invested capital FY2026

ROIC16.8%
On new capital since FY2023 15.5%
Capital employed₹3,591 cr

NOPAT over equity plus debt less cash, at a notional 25% tax. Incremental ROIC is the return on money put in since then — the number that decides whether growth creates value or consumes it.

What is this, and how do I read it?

Return on invested capital, and incremental ROIC — Standard in corporate finance; the incremental form was popularised by Michael Mauboussin as the test of whether growth creates value.

ROIC measures what the business earns on all the capital it employs — equity plus debt, less cash. Incremental ROIC asks a sharper question: what has it earned on the money put in since a chosen year?

NOPAT
Operating profit after a notional tax charge, so the figure is independent of how the company is financed. We use 25%.
Invested capital
Equity plus borrowings less cash — the money actually at work.
Incremental ROIC
Change in NOPAT divided by change in invested capital. If it sits below the cost of capital, growth is destroying value however fast revenue rises.

How to read itROIC comfortably above the cost of capital — call it 11–13% in India — means growth compounds. Below it, growth consumes. Incremental below headline means recent investment is earning less than the legacy business.

Where it failsDistorted in the year of a large acquisition. Understated for companies mid-build, where capital is deployed but capacity has not yet been commissioned — an incubator will look poor until it does not.

Earnings quality ladder FY2026

Cash ÷ EBITDA0.68×
Cash ÷ profit0.80×
Free cash ÷ profit0.42×

Read downward. Cash can cover EBITDA and still not survive capex — the third rung is where a capital-hungry business shows itself.

What is this, and how do I read it?

The earnings quality ladder — Not a named model — the standard sequence an analyst walks when testing whether reported profit is real.

Three ratios read in order, each stricter than the last.

Cash ÷ EBITDA
Does operating profit arrive as cash? Below 0.8 points to working capital absorbing it.
Cash ÷ profit
Does bottom-line profit arrive as cash? Below 1.0 persistently is the classic warning.
Free cash ÷ profit
Does anything survive capex? This is where capital-hungry businesses reveal themselves — a company can pass the first two and still never generate spendable cash.

How to read itRead downward. Each rung failing where the one above passed tells you exactly where the cash is going.

Where it failsA single year of heavy capex depresses the third rung legitimately. Judge it across a cycle.

What the price implies

25.2% free cash flow growth, every year for ten years

The growth rate that makes today's market value equal the discounted cash flows, at a 11.5% discount rate and 4.0% terminal growth. Not a forecast — the arithmetic of what is already in the price. Compare it with what the business has actually delivered.

What is this, and how do I read it?

Reverse DCF — the growth already in the price — A standard inversion of discounted cash flow, used to avoid the forecasting problem entirely.

Instead of forecasting cash flows and deriving a value, it takes today's market value as given and solves for the growth rate that would justify it. The output is not a view — it is the arithmetic of what the market is currently assuming.

Discount rate
The return required for the risk taken. We use 11.5%, roughly the long-run cost of equity in India.
Terminal growth
Growth beyond the explicit ten years. We use 4%, near long-run nominal GDP.
The output
The free-cash-flow growth rate, every year for a decade, that makes the discounted total equal today's market value.

How to read itCompare it with what the business has actually delivered. A price implying 30% a year against a decade of 15% is a demanding assumption; the reverse is a modest one.

Where it failsUseless when free cash flow is negative or unusually depressed, which is common mid-capex. Highly sensitive to the discount rate — a point either way moves the answer materially.

Cost of debt FY2026

Interest ÷ average borrowings0.45%
Average borrowings₹222 cr

Against a policy rate near 6%, most sound Indian corporates borrow between 7% and 10%.

What is this, and how do I read it?

Cost of debt — Interest expense over average borrowings — the effective rate the company actually pays.

What the lenders charge, which is a market verdict on credit quality that no rating agency delay affects.

Well below the policy rate
Suggests interest is being capitalised into assets rather than expensed, or that funding comes from related parties on non-market terms.
Near the policy rate plus a normal spread
Ordinary bank funding. Nothing to explain.
Well above
Lenders are pricing risk the equity market may not yet be.

How to read itAgainst a policy rate near 6%, most sound Indian corporates borrow between 7% and 10%. Read the direction over years as much as the level.

Where it failsUnderstated where a large share of interest is capitalised into projects under construction. Not meaningful for lenders, where interest is cost of goods.

Reading the numbers on this pagetwo bases, both shown

Some figures appear twice on this page with different values. That is not an error — they sit on different bases. The live feed reports a rolling twelve months; everything computed here comes from the last audited statements. Both are shown so you can see which is which.

Operating margin
Trailing twelve months, live feed31.4%
FY2026, as filed35.0%
3.6% apart

Where the two disagree, every model, screen and ratio computed on this page uses the filed figure, because the rest of the page is on that basis.

What the filings we hold do not give

Models that need these lines are withheld rather than estimated: net worth, current assets, current liabilities, trade receivables, inventory, net block. Nothing on this page is back-solved from a figure the company did not publish.

Published screening frameworksrules applied, not opinions quoted

Each framework below is a set of stated, mechanical criteria from published work, run against this company's own filed numbers. Passing or failing a screen is not a verdict — different frameworks disagree by design, and that disagreement is itself informative.

Graham — defensive investor

3 / 5
  • Debt below net worth ₹221 cr vs ₹3,370 cr
  • Positive earnings every year 11 of 11 years
  • Earnings growth over the period 111% since FY2022
  • P/E below 15 30.0×
  • P/E × P/B below 22.5 146.4

Benjamin Graham's stated criteria for a defensive stock, applied to the filed numbers. A company failing several is not disqualified — Graham designed these to be deliberately strict.

Greenblatt — magic formula

1 / 2
  • Return on capital above 20% 22.4%
  • Earnings yield above 8% 3.3%

Two ratios only: what the business earns on its capital, and what you pay for those earnings. Designed to be ranked across a universe rather than read in isolation.

O'Neil — CAN SLIM growth tests

2 / 4
  • Annual earnings growth above 25% 20%
  • Revenue growth above 20% 13%
  • Return on equity above 17% 19.3%
  • Share count not expanding equity capital ₹15 cr

The fundamental half of William O'Neil's framework. The market and leadership components are judgement calls and are not scored here.

Quality — compounder tests

3 / 4
  • Cash conversion above 0.9× 0.75× over 11 years
  • ROCE above 15% 24.0%
  • Interest covered more than 4× 804.00×
  • Debt below half of equity 0.07×

The characteristics long-term holders commonly look for: cash-backed earnings, high returns on capital, and debt that never forces a decision.

Against the sector48 companies

Median of the companies we hold in the same sector (Healthcare). Every figure on both sides is the live feed's trailing twelve months, so the two are measured the same way whatever depth of extraction this company has had. A number only means something next to something else — expensive against the market and cheap against peers are different facts.

P/E
30.0×
47.9×
-37%
P/B
4.9×
6.3×
-22%
Return on equity
21.2%
17.5%
+21%
Operating margin
31.4%
19.1%
+64%
Net margin
29.6%
15.7%
+89%
Dividend yield
0.4%
0.3%
+9%
this companysector median

The page in pictures

Revenue and what it leaves behind

Bars are revenue; the line is net margin. Revenue rising while the line falls is the shape worth noticing.

FY19 · 649FY19FY20 · 863FY20FY21 · 1,061FY21FY22 · 1,269FY22FY23 · 1,467FY23FY24 · 1,694FY24FY25 · 1,937FY25FY26 · 2,187FY26
Revenue (₹ cr)Net margin %

Where the year's cash went — FY2026

Operating cash first, then what the business spent and raised.

523Operating cash−582Investing−46Financing

Quality over time

One year is a snapshot. These are the two lines that matter across a cycle.

5.03.21.5-0.3FY19FY20FY21FY22FY23FY24FY25FY26
Cash ÷ profit (×)ROCE (÷10)

Where cash gets stuck

Rising debtor or inventory days against flat sales is the earliest visible sign of stress.

27519110723FY19FY20FY21FY22FY23FY24FY25FY26
Debtor daysInventory daysPayable daysCash cycle
Growth & valuation workspace

Set your own assumptions and watch the numbers move. A scenario calculator — the outputs are the arithmetic of your inputs.

User-driven scenario tool. Implied value and CAGR follow only from the assumptions you set — not a FinMinutes forecast, recommendation, or target price.

Valuation & quality

One canonical set of figures — the same numbers used everywhere else on this page and on the screener.

What you payHow the price compares with earnings, book and sales.
P/E (TTM)
30.0x
trailing 12m, live feed
P/B
4.88x
P/S
7.65x
PEG
1.35
Dividend yield
0.35%
What it earnsMargins and returns as the live feed reports them, on a rolling twelve months. The models above compute the same measures from the last audited statements, so the two can differ.
Operating margin
31.4%
trailing 12m, live feed
Net margin
29.6%
trailing 12m, live feed
Return on equity
21.2%
trailing 12m, live feed
How it is fundedLeverage and what is returned to shareholders.
Debt / equity
0.00
conservative
Payout ratio
9.1%
Book value / share
₹439.6
Return on equity of 21.2% is built on a 29.6% net margin and debt of 0.00x equity. The full DuPont breakdown sits in the forensic models above.

Ownership & Skin in the Game

How the register has moved over recent quarters — the direction matters more than the level.

Promoter ― 0.00
Sep '2570.57% Dec '2570.57% Mar '2670.57% Jun '2670.57%

Promoter held steady from 70.57% to 70.57% across these quarters.

FII ▼ 0.72
Sep '256.48% Dec '256.55% Mar '266.15% Jun '265.76%

FII trimmed from 6.48% to 5.76% across these quarters.

MF ▲ 0.24
Sep '251.79% Dec '251.97% Mar '262.02% Jun '262.03%

MF rose from 1.79% to 2.03% across these quarters.

Other ▲ 0.48
Sep '2521.16% Dec '2520.91% Mar '2621.26% Jun '2621.64%

Other rose from 21.16% to 21.64% across these quarters.

Working capital12-year series

Where cash gets stuck. A rising inventory or debtor line against flat sales is the earliest sign of trouble in the numbers.

MeasureFY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Debtor days
How long customers take to pay
9097969198117119138
Inventory days
How long stock sits before it sells
47210139149159183159181
Payable days
How long the company takes to pay suppliers
76576810284116103125
Cash conversion cycle
Debtor + inventory − payable days
61251166138173184175194
Working capital days104167145165144166174199
ROCE %
Return on capital employed
45.0%33.0%28.0%28.0%26.0%26.0%26.0%24.0%
Trends

The shape of the business over time (annual) — read the direction, not the single print.

Revenue (₹ cr)
FY20211.1kFY20221.3kFY20231.5kFY20241.7kFY20251.9kFY20262.2k
Net profit (₹ cr)
FY2021251FY2022308FY2023377FY2024461FY2025541FY2026650

Annual Profit & Loss ₹ cr

LineFY2021FY2022FY2023FY2024FY2025FY2026
Revenue from operations1,0611,2691,4671,6941,9372,187
Other income2338556692111
Depreciation374745536673
Finance cost211111
Profit before tax314386451564677803
Net profit (owners)251308377461541650
EPS (₹)32.0339.5649.5760.1970.5684.36

Exceptional items, total income and EBITDA are read from the filed statements.

Quarterly Financials ₹ cr

MetricDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Mar 2016 9m
Revenue436453459483493502510534543600610239
Other Income17171921312623303428344
Expenses293308307318331334332345353396397175
Depreciation14161617161716181919227
Finance cost000000000000
Profit before tax14514615416817717718420120421322560
Net Profit12012112513114014515116016617317946
EPS15.4316.0116.3117.2118.2818.7620.1020.3221.5622.3823.276.05

Balance Sheet ₹ cr, annual

ItemFY2021FY2022FY2023FY2024FY2025FY2026
Equity Capital151515151515
Reserves9541,2521,6492,0842,6193,355
Borrowings235219222219222221
Net block305287280453546580
CWIP1418221117144234
Investments1189281376590859
Total Assets1,3641,7362,1912,6983,2084,038

Cash Flow ₹ cr

LineFY2021FY2022FY2023FY2024FY2025FY2026
Cash from operations269337271318432523
Cash from investing-30-377-216-319-333-582
Cash from financing-24-41-28-38-38-46
Free cash flow19524678173241275
Net change in cash215-8127-3961-105

Cash from operations is the number profit has to answer to. Free cash flow is what remains after the business pays for its own growth.

From the filings, calls & disclosures

The part no one reads: the auditor's opinion, the contingent liabilities buried in the notes, the covenants, and the claims in the deck placed beside the figures that test them.

  • Buried in the footnotes — what the notes disclose and the summary does not
  • Risk register — every dispute, probe and contingent liability with its amount
  • Audit & governance — opinion type, emphasis of matter, going concern, subsidiary coverage
  • Guidance & forward view
  • Narrative vs numbers
  • Segment intelligence
Live once this company's filings, calls and disclosures have been read.
The analyst grilling

Where analysts pressed management on the earnings call, and exactly how management answered — the questions that were hardest to answer are usually the ones that matter.

  • The question, and who asked it
  • Management's answer, in their own framing
Live once this company's filings, calls and disclosures have been read.

Disclosure & evidencewhat the filings actually show

These are coverage counts, not ratings. Each one asks a fixed set of questions of the filings and reports how many the company answered. A company that discloses nothing counts nothing here — that is a statement about the disclosure, not about the business.

Capital discipline

3 of 4 disclosed weighted 7 of 10
What was looked for
  • Profit converts to cash — 0.75× over 11 years
  • Free cash flow not persistently negative — 1 of 12 years negative
  • Capital converts into revenue — capital +62% vs revenue +49%
  • Interest comfortably covered — 804.00×

Others in Healthcare

The same read, applied to the companies this one competes with.

Results · Q1 FY27April to June 2026

Open the full results page ↗
✓Clean on 6 checks6 of 19 checks ran · from the quarterly statements; filing read not yet in
Revenue₹610 cr▲ 19.6%on the year▲ 1.7%on the quarter
EBITDA₹213 cr▲ 19.7%on the yearmargin 34.9% (+2 bps)
Net profit₹179 cr▲ 18.5%on the year▲ 3.5%on the quarter
EPS₹23.27▲ 15.8%on the year

What changed

  1. Revenue ₹610 cr, +19.6% on the year (this quarter has averaged +13.7% over the last 2 years); EBITDA margin 34.9%, +2 bps.
  2. Profit growth was earned in the business: reported +18.5%, core +18.6%.
  3. Every check that could run (6 of 19) came back quiet.

The quarter, explainedfrom the quarterly statements

Caplin Point Laboratories Ltd. reported revenue of ₹610 cr for April to June 2026, +19.6% on the year and +1.7% on the quarter. That is faster than this quarter has grown in recent years (+13.7% on average), so the year-on-year number is not just the season. It is the highest quarterly revenue in the last 12 quarters on record. Over the last four quarters revenue comes to ₹2,287 cr, +15.0% on the four before.

Operating profit (EBITDA) was ₹213 cr, a margin of 34.9%, +2 bps on the year and +92 bps on the quarter. Over the last 8 quarters the margin has ranged from 32.9% to 35.4%, averaging 34.3%. Operating costs grew +19.6%, broadly with revenue, so operating profit kept pace with sales.

Net profit was ₹179 cr, +18.5% on the year and +3.5% on the quarter, with earnings per share of ₹23.27. Profit before other income, one-offs and tax grew 18.6%, so the profit growth came from the business itself. The tax rate of 20% is in line with its recent average. Profit over the last four quarters totals ₹678 cr, +19.6% on the four before.

On earnings per share of ₹87.53 over the last four quarters, the stock at ₹2,298.40 trades at 26.3 times trailing earnings.

Written from the quarterly statements. The filing read adds the balance sheet and cash flow, the auditor's review, segment results, one-off items line by line and what management said on the call.

Questions to ask: none this quartereach one with its numbers and source

No check fired. That is a statement about the checks below, not a verdict on the company.

Could not run on this quarter: Exceptional items that recur, Finance cost rising, Cash behind the profit, Receivables against sales, Inventory against sales, Borrowing while holding cash, Auditor's review or audit report, IPO money used as stated, Related-party transactions, Exits, postponements, restatements, Promoter pledges and allotments, Earlier promises against delivery, When the results were filed. Most need the filing read (balance sheet, cash flow, auditor, disclosures).

Where the profit change came fromJun '25 → Jun '26

₹151 crJun'25+₹35.0 crBusiness(EBITDA)−₹6.0 crDepreciation+₹11.0 crOtherincome−₹11.9 crTax₹179 crJun'26Scale starts at ₹127 cr, not zero, so the changes are visible

Net profit a year ago, each driver's change, and net profit now. Blue added profit, red took it away.

Every quartersame rules, every quarter

Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue₹410 cr₹436 cr₹453 cr₹459 cr₹483 cr₹493 cr₹502 cr₹510 cr₹534 cr₹543 cr₹600 cr₹610 cr
YoY———+16%+18%+13%+11%+11%+11%+10%+20%+20%
EBITDA margin33.4%32.6%32.0%33.1%34.2%32.9%33.5%34.9%35.4%35.0%34.0%34.9%
Other income, % of PBT14%12%12%12%13%18%15%13%15%17%13%15%
Exceptional items————————————
Tax rate20%18%17%19%22%21%18%18%20%19%19%20%
Net profit₹116 cr₹120 cr₹121 cr₹125 cr₹131 cr₹140 cr₹145 cr₹151 cr₹160 cr₹166 cr₹173 cr₹179 cr
YoY———+20%+13%+17%+20%+21%+22%+19%+19%+19%
Core profit YoY———+17%+18%+14%+17%+19%+16%+16%+23%+19%
EPS₹15.13₹15.43₹16.01₹16.31₹17.21₹18.28₹18.76₹20.10₹20.32₹21.56₹22.38₹23.27
Flags···✓✓✓✓✓✓✓✓✓

Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.

DISCLAIMER: FinMinutes is a financial data and analytics platform, not a registered investment adviser. Everything here is for educational and informational purposes. Forensic interpretations are computed from disclosed data and are not recommendations. Do your own due diligence.
Chat on WhatsApp